Iovance Biotherapeutics Stock Price Patterns
| IOVA Stock | USD 2.55 0.08 3.04% |
Momentum 40
Sell Extended
Oversold | Overbought |
EPS Estimate Next Quarter (0.20) | EPS Estimate Current Year (1.08) | EPS Estimate Next Year (0.61) | Wall Street Target Price 8.35 | EPS Estimate Current Quarter (0.26) |
Using Iovance Biotherapeutics hype-based prediction, you can estimate the value of Iovance Biotherapeutics from the perspective of Iovance Biotherapeutics response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Iovance Biotherapeutics using Iovance Biotherapeutics' stock options and short interest. It helps to benchmark the overall future attitude of investors towards Iovance using crowd psychology based on the activity and movement of Iovance Biotherapeutics' stock price.
Iovance Biotherapeutics Short Interest
A significant increase or decrease in Iovance Biotherapeutics' short interest from the previous month could be a good indicator of investor sentiment towards Iovance. Short interest can provide insight into the potential direction of Iovance Biotherapeutics stock and how bullish or bearish investors feel about the market overall.
200 Day MA 2.3708 | Short Percent 0.3183 | Short Ratio 9.38 | Shares Short Prior Month 119.1 M | 50 Day MA 2.4718 |
Iovance Biotherapeutics Hype to Price Pattern
Investor biases related to Iovance Biotherapeutics' public news can be used to forecast risks associated with an investment in Iovance. The trend in average sentiment can be used to explain how an investor holding Iovance can time the market purely based on public headlines and social activities around Iovance Biotherapeutics. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Iovance Biotherapeutics' market sentiment to its price can help taders to make decisions based on the overall investors consensus about Iovance Biotherapeutics.
Iovance Biotherapeutics Implied Volatility | 1.52 |
Iovance Biotherapeutics' implied volatility exposes the market's sentiment of Iovance Biotherapeutics stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Iovance Biotherapeutics' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Iovance Biotherapeutics stock will not fluctuate a lot when Iovance Biotherapeutics' options are near their expiration.
The fear of missing out, i.e., FOMO, can cause potential investors in Iovance Biotherapeutics to buy its stock at a price that has no basis in reality. In that case, they are not buying Iovance because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Iovance Biotherapeutics after-hype prediction price | USD 2.66 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Prediction based on Rule 16 of the current Iovance contract
Based on the Rule 16, the options market is currently suggesting that Iovance Biotherapeutics will have an average daily up or down price movement of about 0.095% per day over the life of the 2026-03-20 option contract. With Iovance Biotherapeutics trading at USD 2.55, that is roughly USD 0.002422 . If you think that the market is fully incorporating Iovance Biotherapeutics' daily price movement you should consider acquiring Iovance Biotherapeutics options at the current volatility level of 1.52%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Check out Iovance Biotherapeutics Basic Forecasting Models to cross-verify your projections. Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Iovance Biotherapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Iovance Biotherapeutics After-Hype Price Density Analysis
As far as predicting the price of Iovance Biotherapeutics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Iovance Biotherapeutics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Iovance Biotherapeutics, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Iovance Biotherapeutics Estimiated After-Hype Price Volatility
In the context of predicting Iovance Biotherapeutics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Iovance Biotherapeutics' historical news coverage. Iovance Biotherapeutics' after-hype downside and upside margins for the prediction period are 0.13 and 8.82, respectively. We have considered Iovance Biotherapeutics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Iovance Biotherapeutics is very risky at this time. Analysis and calculation of next after-hype price of Iovance Biotherapeutics is based on 3 months time horizon.
Iovance Biotherapeutics Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Iovance Biotherapeutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Iovance Biotherapeutics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Iovance Biotherapeutics, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.62 | 6.16 | 0.11 | 0.17 | 25 Events / Month | 6 Events / Month | In about 25 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
2.55 | 2.66 | 4.31 |
|
Iovance Biotherapeutics Hype Timeline
Iovance Biotherapeutics is currently traded for 2.55. The entity has historical hype elasticity of 0.11, and average elasticity to hype of competition of -0.17. Iovance is anticipated to increase in value after the next headline, with the price projected to jump to 2.66 or above. The average volatility of media hype impact on the company the price is over 100%. The price jump on the next news is projected to be 4.31%, whereas the daily expected return is currently at 0.62%. The volatility of related hype on Iovance Biotherapeutics is about 2248.18%, with the expected price after the next announcement by competition of 2.38. Iovance Biotherapeutics currently holds about 424.46 M in cash with (352.98 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.69, which can makes it an attractive takeover target, given it will continue generating positive cash flow. Given the investment horizon of 90 days the next anticipated press release will be in about 25 days. Check out Iovance Biotherapeutics Basic Forecasting Models to cross-verify your projections.Iovance Biotherapeutics Related Hype Analysis
Having access to credible news sources related to Iovance Biotherapeutics' direct competition is more important than ever and may enhance your ability to predict Iovance Biotherapeutics' future price movements. Getting to know how Iovance Biotherapeutics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Iovance Biotherapeutics may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| DNA | Ginkgo Bioworks Holdings | 0.23 | 11 per month | 0.00 | (0.11) | 8.16 | (6.79) | 28.96 | |
| MBX | MBX Biosciences Common | (2.48) | 9 per month | 3.92 | 0.21 | 14.40 | (7.47) | 29.11 | |
| ERAS | Erasca Inc | 1.33 | 8 per month | 2.56 | 0.32 | 15.04 | (4.76) | 50.26 | |
| REPL | Replimune Group | (0.09) | 9 per month | 0.00 | (0.07) | 5.56 | (5.32) | 20.44 | |
| MGTX | MeiraGTx Holdings PLC | (0.09) | 8 per month | 0.00 | (0.06) | 5.08 | (5.18) | 14.00 | |
| MLTX | MoonLake Immunotherapeutics | (1.39) | 9 per month | 3.62 | 0.15 | 8.68 | (6.36) | 35.46 | |
| VIR | Vir Biotechnology | (0.10) | 5 per month | 3.64 | 0.1 | 8.08 | (6.25) | 20.46 | |
| CTMX | CytomX Therapeutics | (0.02) | 9 per month | 4.17 | 0.17 | 10.08 | (8.51) | 30.43 | |
| ATXS | Astria Therapeutics | 0.04 | 5 per month | 1.00 | 0.02 | 2.11 | (1.67) | 6.54 | |
| AVBP | ArriVent BioPharma Common | (0.17) | 4 per month | 3.15 | 0.08 | 6.71 | (6.03) | 18.12 |
Iovance Biotherapeutics Additional Predictive Modules
Most predictive techniques to examine Iovance price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Iovance using various technical indicators. When you analyze Iovance charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Iovance Biotherapeutics Predictive Indicators
The successful prediction of Iovance Biotherapeutics stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Iovance Biotherapeutics, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Iovance Biotherapeutics based on analysis of Iovance Biotherapeutics hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Iovance Biotherapeutics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Iovance Biotherapeutics's related companies. | 2010 | 2025 | 2026 (projected) | Dividend Yield | 0.13 | 0.12 | 0.1 | Price To Sales Ratio | 1.6K | 15.04 | 14.28 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Complementary Tools for Iovance Stock analysis
When running Iovance Biotherapeutics' price analysis, check to measure Iovance Biotherapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Iovance Biotherapeutics is operating at the current time. Most of Iovance Biotherapeutics' value examination focuses on studying past and present price action to predict the probability of Iovance Biotherapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Iovance Biotherapeutics' price. Additionally, you may evaluate how the addition of Iovance Biotherapeutics to your portfolios can decrease your overall portfolio volatility.
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| AI Portfolio Prophet Use AI to generate optimal portfolios and find profitable investment opportunities |